Loading...

Diane Marie Da Silva, PhD, MS

Title(s)Assistant Professor of Research Obstetrics & Gynecology
AddressNRT 7517
Health Sciences Campus
Los Angeles CA 90089-9601
Phone+1 323 442 3868
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Da Silva's current research interests span multiple areas of study that include applying immune modulation strategies to enhance natural and vaccine-induced immunity against solid tumors, investigating the molecular and cellular determinants in the tumor microenvironment that lead to cancer development, progression and metastasis, and assessing the clinical significance of the cervico-vaginal microbiota in relation to gynecologic cancer development, progression and response to treatment.

    Dr. Da Silva has broad expertise and skills associated with immunology, oncology and infectious disease research, immunotherapeutics, vaccine immunogenicity and efficacy, pre-clinical vaccine/adjuvant development, small animal syngeneic and xenograft tumor models, clinical translational research, and analysis of immune responses and biomarkers in human clinical samples for many different types of cancer. Dr. Da Silva is the Technical Director of the Norris Comprehensive Cancer Center Beckman Center for Immune Monitoring, a core resource for collecting, processing and analyzing human clinical trial samples to discover and validate immune-related biomarkers of response to cancer therapies. She has spent the past 15 years studying human papillomavirus (HPV) interactions with host immune cell receptors and immune escape mechanisms used by HPV, and has been involved with development of therapeutic vaccine strategies against HPV-induced cancers.

    Since 2015, Dr. Da Silva is the course director for the undergraduate Introductory course in Modern Oncology and Cancer Biology for the USC Minor in Health Care Studies.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer. JAMA Oncol. 2019 Nov 27. Mayadev JS, Enserro D, Lin YG, Da Silva DM, Lankes HA, Aghajanian C, Ghamande S, Moore KN, Kennedy VA, Fracasso PM, Schilder RJ. PMID: 31774464.
      View in: PubMed   Mentions: 1     Fields:    
    2. Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease. Vaccine. 2019 05 16; 37(22):2915-2924. Da Silva DM, Skeate JG, Chavez-Juan E, Lühen KP, Wu JM, Wu CM, Kast WM, Hwang K. PMID: 31010714.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. BMC Cancer. 2018 Oct 11; 18(1):970. Brunette LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, Brand HE, Lawrenson K, Walia S, Chiriva-Internati M, Groshen S, Roman LD, Kast WM, Da Silva DM. PMID: 30309325.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors. Gynecol Oncol. 2018 10; 151(1):102-110. Rodrigues LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, Oliveira NS, Chavez-Juan E, Da Silva DM, Kast WM, Nicol AF, Pilotto JH. PMID: 30087059.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    5. Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation. Sci Rep. 2018 08 03; 8(1):11642. Taylor JR, Fernandez DJ, Thornton SM, Skeate JG, Lühen KP, Da Silva DM, Langen R, Kast WM. PMID: 30076379.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    6. Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunol Res. 2018 07; 6(7):870-880. Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL. PMID: 29792298.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCellsPHPublic Health
    7. Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response. PLoS One. 2018; 13(1):e0191311. Skeate JG, Da Silva DM, Chavez-Juan E, Anand S, Nuccitelli R, Kast WM. PMID: 29324830.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    8. T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation. Papillomavirus Res. 2016 12; 2:21-30. Woodham AW, Yan L, Skeate JG, van der Veen D, Brand HH, Wong MK, Da Silva DM, Kast WM. PMID: 27182559.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    9. Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro. Virol J. 2016 11 18; 13(1):187. Woodham AW, Sanna AM, Taylor JR, Skeate JG, Da Silva DM, Dekker LV, Kast WM. PMID: 27863502.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    10. Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):27-33. Nicol AF, Brunette LL, Nuovo GJ, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Coutinho JR, Vianna-Andrade C, Oliveira NS, Woodham AW, DA Silva DM, Kast WM. PMID: 27149102.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    11. Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. AIDS Patient Care STDS. 2016 07; 30(7):291-306. Woodham AW, Skeate JG, Sanna AM, Taylor JR, Da Silva DM, Cannon PM, Kast WM. PMID: 27410493.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother. 2016 06 02; 12(6):1418-29. Skeate JG, Woodham AW, Einstein MH, Da Silva DM, Kast WM. PMID: 26835746.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    13. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells. J Interferon Cytokine Res. 2016 05; 36(5):291-301. Da Silva DM, Woodham AW, Naylor PH, Egan JE, Berinstein NL, Kast WM. PMID: 26653678.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    14. Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C. Papillomavirus Res. 2015 Dec 01; 1:12-21. Da Silva DM, Woodham AW, Rijkee LK, Skeate JG, Taylor JR, Koopman ME, Brand HE, Wong MK, McKee GM, Salazar AM, Kast WM. PMID: 26665182.
      View in: PubMed   Mentions: 5     Fields:    
    15. Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection. J Gen Virol. 2016 Feb; 97(2):422-434. Skeate JG, Porras TB, Woodham AW, Jang JK, Taylor JR, Brand HE, Kelly TJ, Jung JU, Da Silva DM, Yuan W, Martin Kast W. PMID: 26555393.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    16. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman LD, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. PMID: 26360252.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    17. A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours. J Gen Virol. 2015 Sep; 96(9):2764-2768. Bogaert L, Woodham AW, Da Silva DM, Martens A, Meyer E, Kast WM. PMID: 26044793.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    18. Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection. J Antimicrob Chemother. 2015; 70(6):1686-90. Woodham AW, Taylor JR, Jimenez AI, Skeate JG, Schmidt T, Brand HE, Da Silva DM, Kast WM. PMID: 25712315.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    19. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes. Prostate. 2015 Feb 15; 75(3):280-91. Yan L, Da Silva DM, Verma B, Gray A, Brand HE, Skeate JG, Porras TB, Kanodia S, Kast WM. PMID: 25399517.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    20. Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression. J Immunol. 2014 May 15; 192(10):4748-57. Woodham AW, Raff AB, Raff LM, Da Silva DM, Yan L, Skeate JG, Wong MK, Lin YG, Kast WM. PMID: 24719459.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    21. Suppression of Langerhans cell activation is conserved amongst human papillomavirus a and ß genotypes, but not a µ genotype. Virology. 2014 Mar; 452-453:279-86. Da Silva DM, Movius CA, Raff AB, Brand HE, Skeate JG, Wong MK, Kast WM. PMID: 24606705.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    22. The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol. 2013 Jun; 87(11):6062-72. Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM. PMID: 23536685.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    23. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One. 2012; 7(8):e43519. Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, Isas JM, Langen R, Kast WM. PMID: 22927980.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    24. Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression. Cancer Res. 2010 May 15; 70(10):3955-64. Kanodia S, Da Silva DM, Karamanukyan T, Bogaert L, Fu YX, Kast WM. PMID: 20460520.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    25. Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer. 2010 Jan 15; 116(2):424-31. Clark JI, Moon J, Hutchins LF, Sosman JA, Kast WM, Da Silva DM, Liu PY, Thompson JA, Flaherty LE, Sondak VK. PMID: 19918923.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    26. A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol. 2009 Nov 15; 183(10):6151-6. Fahey LM, Raff AB, Da Silva DM, Kast WM. PMID: 19864613.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    27. Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clin Cancer Res. 2009 Oct 01; 15(19):6167-76. Smith KA, Meisenburg BL, Tam VL, Pagarigan RR, Wong R, Joea DK, Lantzy L, Carrillo MA, Gross TM, Malyankar UM, Chiang CS, Da Silva DM, Kündig TM, Kast WM, Qiu Z, Bot A. PMID: 19789304.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    28. Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16. J Immunol. 2009 Mar 01; 182(5):2919-28. Fahey LM, Raff AB, Da Silva DM, Kast WM. PMID: 19234187.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    29. Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun. 2008 Apr 24; 8:8. Chiriva-Internati M, Cobos E, Da Silva DM, Kast WM. PMID: 18433090.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    30. Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions. Int J Cancer. 2008 Jan 15; 122(2):247-59. Kanodia S, Da Silva DM, Kast WM. PMID: 17973257.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    31. Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. J Immunol. 2007 Jun 15; 178(12):7587-97. Da Silva DM, Fausch SC, Verbeek JS, Kast WM. PMID: 17548594.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    32. Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro. Hum Immunol. 2005 Jul; 66(7):762-72. Warrino DE, Olson WC, Scarrow MI, D'Ambrosio-Brennan LJ, Guido RS, Da Silva DM, Kast WM, Storkus WJ. PMID: 16112023.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    33. Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation. J Immunol. 2005 Jun 01; 174(11):7172-8. Fausch SC, Fahey LM, Da Silva DM, Kast WM. PMID: 15905561.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    34. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells. Vaccine. 2005 Feb 25; 23(14):1720-9. Fausch SC, Da Silva DM, Kast WM. PMID: 15705478.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    35. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res. 2003 Jul 01; 63(13):3478-82. Fausch SC, Da Silva DM, Kast WM. PMID: 12839929.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    36. Cervical cancer vaccines: recent advances in HPV research. Viral Immunol. 2003; 16(2):111-21. Eiben GL, da Silva DM, Fausch SC, Le Poole IC, Nishimura MI, Kast WM. PMID: 12828864.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    37. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J Immunol. 2002 Sep 15; 169(6):3242-9. Fausch SC, Da Silva DM, Rudolf MP, Kast WM. PMID: 12218143.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    38. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Intervirology. 2002; 45(4-6):300-7. Wakabayashi MT, Da Silva DM, Potkul RK, Kast WM. PMID: 12566713.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    39. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines. Virology. 2001 Nov 25; 290(2):350-60. Da Silva DM, Pastrana DV, Schiller JT, Kast WM. PMID: 11883199.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    40. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol. 2001 May 15; 166(10):5917-24. Rudolf MP, Fausch SC, Da Silva DM, Kast WM. PMID: 11342606.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    41. Physical interaction of human papillomavirus virus-like particles with immune cells. Int Immunol. 2001 May; 13(5):633-41. Da Silva DM, Velders MP, Nieland JD, Schiller JT, Nickoloff BJ, Kast WM. PMID: 11312251.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    42. A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy. Clin Cancer Res. 2001 Mar; 7(3 Suppl):876s-881s. Small LA, Da Silva DM, de Visser KE, Velders MP, Fisher SG, Potkul RK, Kast WM. PMID: 11300486.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    43. Cervical cancer vaccines: emerging concepts and developments. J Cell Physiol. 2001 Feb; 186(2):169-82. Da Silva DM, Eiben GL, Fausch SC, Wakabayashi MT, Rudolf MP, Velders MP, Kast WM. PMID: 11169454.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    44. Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune response. J Cell Biochem. 1999 May 01; 73(2):145-52. Nieland JD, Da Silva DM, Velders MP, de Visser KE, Schiller JT, Müller M, Kast WM. PMID: 10227378.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    45. Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles. Biol Chem. 1999 Mar; 380(3):335-40. Rudolf MP, Nieland JD, DaSilva DM, Velders MP, Müller M, Greenstone HL, Schiller JT, Kast WM. PMID: 10223336.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    46. Papillomavirus virus-like particles as anticancer vaccines. Curr Opin Mol Ther. 1999 Feb; 1(1):82-8. Da Silva DM, Velders MP, Rudolf MP, Schiller JT, Kast WM. PMID: 11249689.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    Diane's Networks
    Concepts (245)
    Derived automatically from this person's publications.
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _